Молодежный инновационный вестник

2415-7805

Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации

10021

Conference Proceedings

The possibilities of using combined oral contraceptives for pharmacotherapy of premenstrual syndrome and dysmenorrhea in concomitant disorders of a psycho-neurological nature

Mostovskaya

Esenia Aleksandrovna

Student of Volgograd State Medical Universitychydo-skazka@yandex.ruhttps://orcid.org/0009-0008-2655-4681Koshkina

Astra Tsezarevna

orangeroseniksend@mail.comKurushina

Olga

ovkurushina@mail.ruhttps://orcid.org/0000-0003-4364-0123Burova

Natalia

kafedraAG@yandex.ruhttps://orcid.org/0000-0002-0546-8732Nurullina

Tatyana

clinpharmvolg@gmail.comhttps://orcid.org/0000-0001-8751-2524

27122024

1328586

15042024

16062024

2024

Symptoms of PMS and dysmenorrhea are detected in 95% of women aged 15 to 45 years, and neuropsychiatric disorders are a significant risk factor. Hormone therapy is often used, but it is not always possible. Goal. To evaluate the differences in the manifestations of PMS, dysmenorrhea and DDTS when using combined oral contraceptives. Materials and methods. A survey of Volgograd female students with an assessment of the neuropsychiatric status and frequent symptoms of PMS and dysmenorrhea in different periods of the cycle. Results. The average age of the examined patients was 21.8 4.1 years. The normal BMI is 77.5%. All the examined patients were divided into groups: taking COCA and protecting themselves with non-hormonal means. Among COCA users, indicators of PMS and dysmenorrhea of high and moderate levels are less common than in those who are protected by non-hormonal methods or are not protected at all. There are also significant differences in the indicators of neuropsychiatric disorders with a better outcome in the examined patients who take COCA. Conclusions. The surveyed people who take COCA have significantly fewer reproductive and neuropsychiatric disorders than those who do not take COCA.

фармакотерапияоральные контрацептивыпредменструальный синдромдисменореядистрессдепрессиятревожностьсоматизация

Логинова, К.Б. Предменструальный синдром в популяции женщин Российской Федерации (эпидемиологическое исследование) / К.Б. Логинова, Г.М. Дюкова, Ю.Э. Доброхотова // Проблемы репродукции. – 2019. — №25(1). – С. 34 – 40.